Tools and Approaches
In addition to providing expanded
support for prevention and control programs, USAID supports
three critical research efforts: (a) the Agency's Malaria
Vaccine Development Program (MVDP) and (b) the development
of new drug therapies for malaria, and (c) operations research
on behavioral, community, drug use and treatment regimen
compliance issues as well as potential community approaches
to environmental management of malaria.
The goal of the MVDP is to accelerate
progress towards the availability of a malaria vaccine,
which can be used as part of malaria control efforts. USAID-supported
clinical trials for new treatment therapies for malaria
are designed to ensure the timely availability of a malaria
vaccine, which can be used as part of malaria control efforts.
Similarly, extra funding for ongoing USAID supported clinical
trials for new treatment therapies for malaria would ensure
the timely availability of alternative treatments for malaria
- an increasingly critical issue in light of the emergence
and spread of resistance to existing antimalarial drugs.
Lastly targeted and expanded operations research efforts
will help guide treatment policy and practice, as well as
behavior change communication.
|